ISPC — iSpecimen Inc.

Nasdaq · Health Care · Life Sciences Tools & Services · CIK 1558569 ·
Last close
$3.38
Market Cap
$4.86M
52W High
$17.44
52W Low
$3.20
ADV30
1,212,295
Next earnings
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. The company's marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 156,009 71,599 -2,538,403 -2,275,221 6,609,658 2,818,989 5,795,620
Dec 2025 51,761 -547,078 -2,687,882 -5,001,245 9,531,410 6,880,835 6,443,179
Sep 2025 106,592 -98,001 -2,830,222 -2,780,648 8,997,557 2,782,758 5,924,846
Jun 2025 713,135 268,958 -1,821,426 -1,047,243 6,034,501 588,775 5,412,528

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-4,240,608
Investing CF
$-1,000,454
Financing CF
$10,243,489
CapEx
$-1,253,011
Dividends Paid
Buybacks
$0
EPS Diluted TTM
$-148.40
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-82,350,149
Inventory
$0
Receivables
$48,298
ST Investments
$0
EBIT TTM
$-10,465,925
Pretax Income TTM
$-10,487,532
Interest Exp TTM
$21,607
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,027,497
EBITDA
$-9,680,486
Free Cash Flow
$-5,687,161
Enterprise Value
$2,394,191
Total Cash
$2,818,989
Total Debt
$254,989
Shares Out
1,437,157
Trailing EPS
$-329.05
Book Value
$1.10
ROE
-894.6%
ROA
-91.8%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,928,998 -8,977,919 -10,487,532 9,531,410 6,443,179 -4,240,608
Dec 2024 9,291,115 -12,728,045 -12,497,805 9,350,230 6,039,222 -8,263,713
Dec 2023 9,928,184 -11,169,349 -11,099,488 15,819,137 6,078,060 -5,807,550
Dec 2022 10,402,303 -10,186,082 -10,245,922 24,617,653 4,308,483 -5,817,720

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.79

Peers — same industry

TickerNameMarket CapLastDaily %
BUDZ WEED, INC. $5.04M $0.03
CDIO Cardio Diagnostics Holdings, Inc. $5.24M $1.77
CBIH Cannabis Bioscience International Holdings, Inc. $3.49M $0.00
BIAF bioAffinity Technologies, Inc. $7.48M $1.65
BMRA BIOMERICA INC $7.63M $2.47

News headlines (Yahoo Finance, 1h cache)

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
2026-05-12 18:16 · Yahoo
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
2026-05-09 01:04 · Yahoo
iSpecimen Announces 1-for-40 Reverse Stock Split
2026-04-24 13:00 · Yahoo
iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time
2026-04-09 20:05 · Yahoo
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research
2026-03-16 11:47 · Yahoo
BC-Most Active Stocks
2026-03-13 14:30 · Yahoo
Wall Street Set to Open Higher Friday as Investors Parse Inflation Data, Oil Prices
2026-03-13 13:23 · Yahoo
iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching
2026-03-12 20:05 · Yahoo
iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete
2026-02-06 14:30 · Yahoo
Nuwellis Announces Changes to Board of Directors
2026-01-23 21:40 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.